(S1 (S (S (NP (NP (NN Trib1)) (CC and) (NP (NN Evi1))) (VP (VBP cooperate) (PP (IN with) (NP (NP (NP (NN Hoxa)) (CC and) (NP (NN Meis1))) (PP (IN in) (NP (JJ myeloid) (NN leukemogenesis))))))) (. .)))
(S1 (S (S (S (NP (NP (JJ Cooperative) (NN activation)) (PP (IN of) (NP (NP (NN Meis1)) (CC and) (NP (NN Hoxa9))))) (VP (VP (VBZ perturbs) (NP (JJ myeloid) (NN differentiation))) (CC and) (VP (ADVP (RB eventually)) (VBZ leads) (NP (JJ myeloid) (NNS progenitors)) (PP (TO to) (NP (NN leukemia)))))) (, ,) (CC yet) (S (NP (PRP it)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN clarified)) (SBAR (WHNP (WP what)) (S (NP (NP (NNS kinds)) (PP (IN of) (NP (JJ subsequent) (JJ molecular) (NNS processes)))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (NN development)) (PP (IN of) (NP (JJ overt) (NN leukemia))))))))))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB understand) (NP (NP (DT the) (JJ molecular) (NN pathway)) (PP (IN in) (NP (JJ Hoxa9/Meis1-induced) (NN leukemogenesis))))))) (, ,) (NP (JJ retroviral) (JJ insertional) (NN mutagenesis)) (VP (VBD was) (VP (VBN applied) (S (VP (VBG using) (NP (JJ retrovirus-mediated) (NN gene) (NN transfer))))))) (. .)))
(S1 (S (S (S (NP (NP (DT The) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (JJ Hoxa9/Meis1-transduced) (NN bone) (NN marrow) (NNS cells)))))) (VP (VBD developed) (NP (NP (JJ acute) (JJ myeloid) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN AML)) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (NP (NN Trib1)) (, ,) (NP (NN Evi1)) (, ,) (NP (NN Ahi1)) (, ,) (NP (NN Raralpha)) (, ,) (NP (NN Pitpnb)) (, ,) (CC and) (NP (NN AK039950))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (NP (NN candidate) (JJ cooperative) (NNS genes)) (ADJP (JJ located) (PP (IN near) (NP (JJ common) (JJ retroviral) (NN integration) (NNS sites)))))))))) (. .)))
(S1 (S (S (S (NP (NP (NN Trib1)) (CC and) (NP (NN Evi1))) (VP (VBD were) (VP (VBN up-regulated) (PP (JJ due) (TO to) (NP (JJ retroviral) (NNS insertions)))))) (, ,) (CC and) (S (NP (NP (NN coexpression)) (PP (IN of) (NP (DT these) (NNS genes)))) (ADVP (RB significantly)) (VP (VBD accelerated) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (JJ Hoxa9/Meis1-induced) (NN AML)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN Trib1)) (CC and) (NP (NN Evi1))) (VP (VBP are) (NP (DT the) (JJ key) (NNS collaborators)))))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN Trib1)) (PP (IN by) (NP (PRP itself)))) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (JJ myeloid) (NN oncogene)) (, ,) (S (VP (VBG enhancing) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN ERK))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN apoptosis)))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (JJ specific) (NN oncogene) (NN interaction))) (PP (IN in) (NP (JJ myeloid) (NN leukemogenesis)))))) (. .)))
